An Exploratory Genetic Study in Participants With Psoriasis
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the association between genetic factors and response
to treatment (guselkumab, ustekinumab, adalimumab, or etanercept) and psoriasis (scaly skin
rash).